Dupuytren's disease is the common inherited tissue-specific fibrotic disorder. It's characterized 2 by progressive and irreversible fibroblastic proliferation affecting the palmar fascia of the hand, 3 with an onset typically in the sixth decade of life. Although genome-wide association studies 4 (GWAS) have identified 24 genomic regions associated with Dupuytren's risk, the biological 5 mechanisms driving signal at these regions remain elusive. We identify potential biological 6 mechanisms for Dupuytren's disease by integrating the most recent, largest GWAS (݊ ௦ ௦ ൌ 7 ି ସ ), which suggests a shared genetic etiology. We further 15 refine the genome-wide genetic correlation signal to identify 8 regions significantly negatively 16 correlated with BMI and 3 regions significantly correlated (1 positively and 2 negatively 17 correlated) with HDL; none of these regions contained the novel gene association identified by 18 TWAS. Our results are consistent with previous epidemiological findings which show that lower 19 BMI increases risk for Dupuytren's disease. These 12 novel risk regions provide new insight into 20 the biological mechanisms of Dupuytren's disease and serve as a starting point for functional 21 validation. 22
) to 8 perform a transcriptome-wide association study (TWAS). We identify 43 tissue-specific gene 9 associations with Dupuytren's risk, one of which resides at least 0.5 Mb away from the 24 risk 10 regions previously identified. We also estimate the genome-wide genetic correlation between 11
Dupuytren's disease and 45 complex traits and find significant genetic correlations between 12
Dupuytren's disease and body mass index ( ), located in the intron of EPDR1, revealed an effect on expression and 37 protein secretion of the nearby gene SFRP4 4 but implicated EPDR1 functionally 6 . Overall, the 38 regulatory mechanisms driving signal at the GWAS associations on DD remains unknown. 39
In this study, we aimed to explore genetic mechanisms at known risk regions for DD, 40 identify complex traits with possible shared genetic etiologies, and find novel risk regions for 41 DD. Recently, transcriptome-wide association studies 7,8 (TWAS) have emerged as a way to 42 identify associations between gene expression and a trait. We performed a multi-tissue TWAS by 43 combining a recent DD GWAS 4 with expression quantitative trait loci 9-14 (eQTL), integrating 44 gene expression from five consortia in 43 unique tissues, to test for association between expression and DD in 15,198 genes. We identified 43 associations between tissue-specific gene 46 expression and DD, including one novel risk region on chromosome 17. Next, we aimed to 47 understand the genetic relationship between DD and 45 other complex phenotypes by identifying 48 traits that have genetic correlation (i.e., the similarity in genetic effects across two traits) 49 providing etiological insights and plausible causal relationships to investigate [15] [16] [17] [18] . We performed 50 genetic correlation analyses through cross-trait linkage disequilibrium (LD) score regression 15 51 (LDSC), and find that body mass index (BMI), type II diabetes (T2D), triglycerides (TG), and 52 high-density lipoprotein (HDL) levels are significantly genetically correlated with DD. 53
Additionally, we sought to further refine and understand these relationships with DD and BMI, 54 T2D, TG, and HDL by exploring local regions with enrichments of genetic correlation using ρ -55 HESS 16 , and found 8 risk regions significantly correlated with BMI and 3 risk regions 56 significantly correlated with HDL. Finally, we aimed to identify a tissue or cell type to prioritize 57 when studying DD. 58 . 103
Materials and
We also aimed to find evidence for putative causal relationships between DD and other 104 genetically correlated traits. We used the implementation in ρ -HESS based on a previously 105 described method 18 to prioritize putative causal models between pairs of complex traits. 106
Essentially, for two complex traits, the local genetic correlation is evaluated at regions harboring 107 genome-wide significant GWAS signals specific to each trait. The local genetic correlation for 108 all trait 1 specific regions are summed ‫்̂ݎ(‬ 1 , ௦
) and the local genetic correlation for all trait 2 109 specific regions are summed ‫்̂ݎ(‬ 2 , ௦
). Confidence intervals are determined by 1.96 times 110 jackknife standard error on each side; significance is determined if the confidence intervals do 111 not overlap. The intuition behind this test is that if trait 1 causally influences trait 2 then trait 1 112 specific regions would have strong genetic correlation with trait 2 but trait 2 specific regions 113 would not have strong genetic correlation with trait 1. Thus, we can leverage the difference in 114 correlations for trait-specific signal at these regions to see if the correlations are consistent with a 115 suggestive causal model 16,18 . 116 Tissue and cell type prioritization 117 To identify tissues and/or cell types that are biologically relevant to DD, we used stratified LD 118 score regression to estimate the enrichment of DD SNP-heritability in 205 publicly available 119 specifically expressed gene (SEG) annotations, each of which represents a set of genes that are 120 specifically expressed in a single tissue or cell type (LDSC-SEG) 24 . Briefly, the 205 annotations 121 were originally created from two datasets: RNA-seq gene expression measurements in 53 human 122 tissues from GTEx v6p 9 (average of 161 samples per tissue), and a microarray gene expression 123 dataset comprised of 152 tissues and cell types from either human, mouse, or rat (the "Franke 124
Lab" dataset) 25, 26 . For each set of specifically expressed genes, an annotation was created by 125 adding 100-kb windows upstream and downstream from the transcribed region of each gene. In 126 addition, we tested for enrichment of DD SNP-heritability in a set of 489 publicly available 127 tissue-or cell type-specific chromatin annotations 24 . 396 of these annotations were originally 128 created from five activating histone marks (H3K27ac, H3K4me3, H3K4me1, H3K9ac, and 129 H3K36me3) and DNase I hypersensitivity (DHS) regions that were present in a subset of 88 130 tissues and cell types in the Roadmap Epigenomics Consortium 27 . An additional 93 annotations 131 were created from a set of four activating histone marks (H3K27ac, H3K4me3, H3K4me1, and H3K36me3) in 27 tissues from EN-TEx 28 that were also present in GTEx. Details on the 133 construction of both the SEG annotations and chromatin-based annotations can be found in the 134 original study 24 . Each annotation was tested individually for enrichment of DD SNP-heritability 135 on top of the baseline-LD model 29 by assessing whether the expected additional per-SNP 136 heritability contribution due to the annotation is significantly nonzero (FDR < 0.1). 137
We also employed the web application FUMA 30 in the aim of finding tissues or cell types 138 with differentially expressed genes relevant to DD. FUMA maps GWAS results to create a gene 139 set in three ways: (1) To explore putative biological mechanisms at known DD risk regions, we performed a multi-155 tissue TWAS to identify genes (specifically, cis-regulated gene expression), associated with DD 156 (see Materials and Methods). Briefly, TWAS identifies candidate risk genes for DD by 157 integrating results from GWAS and reference panels of gene expression measurements from 158 eQTL studies to associate cis-regulated expression with DD, while accounting for LD. We used 159 tissue reference panels from GTEx 9 , METSIM 10 , YFS 11,12 , CMC 13 , and NTR 14 resulting in 47 160 different reference tissue panels with a combined sample size of 3,975 (see Materials and 161
Methods; Supplementary Table 1 ). Using these reference panels, we tested 98,147 tissue-specific 162 gene models and found 43 significant tissue-specific gene-trait associations at a Bonferroni-163 Table 1 , Supplementary Table 2 ). GWAS SNP 164 association strength and TWAS tissue-specific gene model association strength can be seen in 165 Figure 1 . These 43 significant models were composed of 18 genes among 23 tissue panels-7 166 genes were significant in multiple tissues ( Table 1) . 36 of the 43 significant tissue-specific gene 167 models were within 0.5Mb of any of the previously identified 24 risk regions. 168
One region of interest is on chromosome 7, where EPDR1 was found to be significant in 169 10 different tissue panels (most significant in lung tissue,
). This region has 170 been previously investigated because of its strong association signal (Odds Ratio 1.93 and 171
) with DD 4 . The variant with the strongest association in this region, 172 rs16879765, is in an intron of EPDR1. Although decreased secretion of the nearby WNT-agonist 173 SFRP4 was correlated with the high risk genotype 4 , genetic and functional evidence point toward 174 EPDR1 being the disease-relevant gene for this region, which has been functionally validated as 175 contributing to myofibroblast contractility 6 . All three transcripts of EPDR1 are found in affected 176 DD tissue and knockdown of EPDR1 attenuates contractility in fibroblast-populated collagen 177 lattice assays 6 ). There were 12 tissue panels that 193 expression for TMEM106A was modeled from ( Supplementary Table 3 ) . 194 Estimates of SNP-heritability in DD are higher than previously proposed 195 We obtained a SNP-heritability estimate of 0.67 (s.e. = 0.08), using LDSC 59 . We also used 196
Heritability Estimator from Summary Statistics (HESS), a previously described method using 197 similar framework as ρ -HESS that estimates local SNP-heritability, and found the total SNP-198 heritability to be 0.532 (s.e. = 0.282), similar to the previous estimate of 0.533 using GCTA 4,5 . 199 Because HESS is optimized for GWAS with sample sizes greater than 50,000 ( ) between 225 DD and BMI, three regions between DD and HDL, and no regions between DD and TG or 226 between DD and T2D (Table 3) . Of these 11 regions, three contained a genome-wide significant 227 association in the DD GWAS 4 . Only one of the 11 regions contained significant tissue-specific 228 gene models from TWAS; the 10 models for EPDR1 were within the DD and HDL genetically 229 correlated 7:37555184-38966703 region (Supplemental Table 2 , Table 3 ). 230
Genetic correlation patterns of BMI/TG and DD consistent with putative causality 231 To further elucidate the relationships of these traits with DD, we used ρ -HESS 16 to test for 232 evidence of putative causality through GWAS estimated genetic effects for BMI, HDL, TG, and 233 T2D acting on DD or vice versa (see Materials and Methods). Both BMI and TG showed 234 suggestive patterns that would be consistent with a putative causal relationship with DD, while 235 HDL and T2D did not (Figure 3, Supplemental Figure 1 ). For example, when considering BMI 236 and DD, the correlation at 399 BMI-specific regions (-0.27, s.e. = 0.044) is seemingly stronger 237 than the correlation at 19 DD-specific regions (-0.03, s.e. = 0.15), indicating that regions that 238 increase BMI tend to decrease risk of DD; this is consistent with a model where BMI genetic 239 effects decrease risk of DD (Figure 3) . The same is true for TG and DD; the correlation at 65 240 TG-specific regions (-0.3, s.e. = 0.08) is seemingly stronger than the correlation at 22 DD-241 specific regions (0.018, s.e. = 0.2; Figure 3 ). Both of these results are not significant (assessed by 242 overlap of confidence intervals, Supplementary Table 5 ). Among the 489 chromatin annotations, we found that esophageal-255 mucosa tissue was the most enriched for DD SNP-heritability, however none of 489 annotations 256 were statistically significant (FDR < 0.1; Supplementary Table 6 ). Next, we prioritized tissues 257 and cell types using FUMA 30 , a platform to visualize and interpret GWAS summary statistics 258 (see Materials and Methods). After using FUMA to create a gene set from the GWAS statistics, 259 we first performed a gene property analysis (which tests if gene expression in a single tissue or 260 cell type is statistically different than the average gene expression across all tissues or cell types) 261 in 53 tissue types 9 . Although none of the 53 tissues showed a significant effect (ܲ Table 8 ). We also performed a gene property analysis using cell type specific 267 expression data for 5115 study-defined cell types from 28 scRNA-seq studies 32-58 . While none of 268 the single cell types were significant (ܲ
), stromal cells and muscle cells were among 269 the top five results ( Supplementary Table 9 ). As a final analysis, we averaged the ) for the 43 significant TWAS models within each tissue to determine which tissue had 271 the most enrichment of TWAS signal. We found adipose subcutaneous tissue was most enriched 272 among the 23 tissues with significant TWAS models ( Supplementary Figure 2) . Because of the 273 lack of consistency between methods and lack of statistical significance in many methods, we are 274 lead to believe that likely the relevant tissue or cell type is not represented in current datasets. 275
Discussion 276
In this work, we aimed to better understand the genetic architecture of DD, find plausible 277 biological mechanisms at known risk regions for DD, understand the relationship between DD 278 and a variety of other traits, and identify possible novel risk regions through local genetic 279 correlation with other traits or genetic-mediated gene expression effects. We highlight that the 280 estimated SNP-heritability of DD (0.53-0.67) is relatively close to estimates of heritability from 281 twin studies (0.8). We also note that the strong concentration of DD GWAS signal in a handful 282 of genomic regions is more consistent with an oligogenic architecture than a polygenic one, 283
suggesting that further functional studies could be particularly fruitful as compared to more 284 polygenic traits and diseases. We also identify a negative genetic correlation between DD and 285 BMI, supporting a previous epidemiological study that observationally showed a negative 286 correlation between the traits 63 ; understanding the relationship between DD and BMI as well as 287 that between DD and TG could shed light on shared biologically important pathways. Finally, we 288 identify one novel risk region from TWAS, and identify 11 regions with significant local genetic 289 correlation between DD and BMI or HDL. Overall, our findings highlight the need for more 290 investigation into these regions as a first step. 291
Additionally, we note a few caveats in our results. First, though the sample size of 8,557 292 for the DD GWAS is the largest yet, it is possible that additional GWAS regions remain 293 undiscovered due to the limit in power and this also would further reduce power to fully detect 294 associations and relationships with other traits. Second, while the patterns of genetic correlation 295 between BMI and DD as well as TG and DD are somewhat consistent with causal relationships, 296 true causality between these traits cannot be determined without functional experimentation. 297
Third, we emphasize that TWAS may not detect the true mechanism of disease if the gene 298 expression is not mediated through genetics or if disease-relevant tissue is not well-represented 299 in available gene expression reference panels. This may be further illustrated by the fact we were 300 unable to identify a specific tissue or cell type to prioritize for further study in DD. This could 301 also be due to the small sample size of the DD GWAS, the cell-type specificity of enhancer 302 elements, or again the publication bias away from musculoskeletal connective tissues, leading to 303 a gap in the available datasets. 304 Future work should be taken in multiple directions. First, we provide additional evidence 305 that EPDR1 may contribute to the pathogenesis of DD; further work should be dedicated to 306 functionally validate and understand this gene in connection with DD, as it may represent an 307 attractive therapeutic target. Second, there is strong evidence for a relationship between BMI/TG 308 and DD-elucidating the mechanism may lead to interesting observations with implications for 309 the treatment of both traits. Third, additional GWAS, with larger sample sizes and in additional 310 populations, will uncover more of the contribution of genetic variation to DD. And fourth, given 311 the putative oligogenic architecture of DD, and that our tissue and cell type analyses lacked 312 consistent results, it might also be rewarding to generate more functional -omics data, such as 313 reference gene expression panels or chromatin accessibility data in the palmar fascia tissue. 314 
